Clinical Research Directory
Browse clinical research sites, groups, and studies.
Taiwan Registry of Hypertrophic Cardiomyopathy (THIC) Research Synopsis
Sponsor: Far Eastern Memorial Hospital
Summary
Hypertrophic cardiomyopathy (HCM) is hallmarked by the presence of left ventricular hypertrophy (LVH) and may present various symptoms including arrhythmia and heart failure. Mutations in the genes related to sarcomeric proteins and metabolic disorders are known causes of HCM. However, it remains required to further explore the prevalence of HCM in the context of Taiwanese' genetic background. Additionally, certain rare diseases that affect the heart, including Fabry disease, cardiac amyloidosis, may present LVH, which makes precise diagnosis among HCM and these diseases more challenging. In this TSOC multi-center registry, we aim to systematically evaluate the clinical, genetic, biochemical features,prevalence, and possible natural course of HCM and relevant rare diseases such as Fabry disease in Taiwan. In the meanwhile, we may also generate the specific "red-flag" signs of Fabry disease in Taiwan.
Key Details
Gender
All
Age Range
20 Years - Any
Study Type
OBSERVATIONAL
Enrollment
2600
Start Date
2023-02-06
Completion Date
2027-12-01
Last Updated
2024-07-26
Healthy Volunteers
No
Conditions
Locations (1)
Far Eastern Memorial Hospital
New Taipei City, Taiwan